» Articles » PMID: 32809209

Non-Pharmacological Management of Painful Peripheral Neuropathies: A Systematic Review

Overview
Journal Adv Ther
Date 2020 Aug 19
PMID 32809209
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Peripheral neuropathic pain (PNP) is defined as the neuropathic pain that arises either acutely or in the chronic phase of a lesion or disease affecting the peripheral nervous system. PNP is associated with a remarkable disease burden, and there is an increasing demand for new therapies to be used in isolation or combination with currently available treatments. The aim of this systematic review was to evaluate the current evidence, derived from randomized controlled trials (RCTs) that assess non-pharmacological interventions for the treatment of PNP.

Methods: After a systematic Medline search, we identified 18 papers eligible to be included.

Results: The currently best available evidence (level II of evidence) exist for painful diabetic peripheral neuropathy. In particular, spinal cord stimulation as adjuvant to conventional medical treatment can be effectively used for the management of patients with refractory pain. Similarly, adjuvant repetitive transcranial magnetic stimulation of the motor cortex is effective in reducing the overall pain intensity, whereas adjuvant static magnetic field therapy can lead to a significant decrease in exercise-induced pain. Weaker evidence (level III of evidence) exists for the use of acupuncture as a monotherapy and neurofeedback, either as an add-on or a monotherapy approach, for treatment of painful chemotherapy-induced peripheral neuropathy CONCLUSIONS: Future RCTs should be conducted to shed more light in the use of non-pharmacological approaches in patients with PNP.

Citing Articles

Nonpharmaceutical treatment of distal sensorimotor polyneuropathy in diabetic patients: an unblinded randomized clinical trial.

Strobel A, Laputsina V, Heinze V, Schulz S, Wienke A, Reer M BMC Complement Med Ther. 2025; 25(1):93.

PMID: 40050870 PMC: 11887202. DOI: 10.1186/s12906-025-04830-0.


An Open-Label Comparative Study of the Impact of Two Types of Electrical Stimulation (Direct Current Neuromuscular Electrical Stimulation and Transcutaneous Electrical Stimulation) on Physical Therapy Treatment of Diabetic Peripheral Neuropathy.

Kostopoulos D, Rizopoulos K, McGilvrey J, Hauskey J, Courcier J, Connor-Israel K J Diabetes Res. 2025; 2025:9970124.

PMID: 39949402 PMC: 11824710. DOI: 10.1155/jdr/9970124.


Comparison of the effect of separate and simultaneous application of Tecar therapy and low-level laser therapy on the neurological symptoms of type 2 diabetic patients with peripheral neuropathy of lower limbs.

Javan Amoli M, Khademi-Kalantari K, Niajalili M, Daryabor A, Naimi S Turk J Phys Med Rehabil. 2024; 70(3):344-357.

PMID: 39679116 PMC: 11639497. DOI: 10.5606/tftrd.2024.13419.


RNA Interference Unleashed: Current Perspective of Small Interfering RNA (siRNA) Therapeutics in the Treatment of Neuropathic Pain.

Saha P, Sharma S ACS Pharmacol Transl Sci. 2024; 7(10):2951-2970.

PMID: 39416962 PMC: 11475279. DOI: 10.1021/acsptsci.4c00329.


A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET.

Sayed D, Deer T, Hagedorn J, Sayed A, DSouza R, Lam C J Pain Res. 2024; 17:1461-1501.

PMID: 38633823 PMC: 11022879. DOI: 10.2147/JPR.S451006.